Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MONICA KRAFT

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1023192937
CMS profile
420992
Location
NEW YORK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$77,602.25

43 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $27,424.08 6
GlaxoSmithKline, LLC. $21,162.12 11
Regeneron Pharmaceuticals, Inc. $11,158.75 8
Genentech USA, Inc. $8,188.90 8
Chiesi USA, Inc. $6,307.65 6
AstraZeneca Pharmaceuticals LP $3,360.75 4

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

43 matching records · $77,602.25 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 43 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–43 of 43.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $1,950.0012/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116289259 CMS
AstraZeneca Pharmaceuticals LP $1,074.0011/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105569155 CMS
GENZYME CORPORATION $58.6411/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139598535 CMS
Genentech USA, Inc. $1,320.0010/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075668 CMS
GlaxoSmithKline, LLC. $2,600.0010/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116324568 CMS
GlaxoSmithKline, LLC. $1,300.0010/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116130536 CMS
Genentech USA, Inc. $325.9010/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075652 CMS
Genentech USA, Inc. $2,970.0010/05/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075656 CMS
Genentech USA, Inc. $56.5910/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075660 CMS
Genentech USA, Inc. $407.5810/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075664 CMS
AstraZeneca Pharmaceuticals LP $3.7509/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105234640 CMS
Regeneron Pharmaceuticals, Inc. $377.5008/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401249 CMS
Regeneron Pharmaceuticals, Inc. $1,887.5008/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401251 CMS
Regeneron Pharmaceuticals, Inc. $188.7508/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401253 CMS
Regeneron Pharmaceuticals, Inc. $755.0008/30/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401255 CMS
Chiesi USA, Inc. $1,350.0008/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811416 CMS
GlaxoSmithKline, LLC. $46.9208/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116456475 CMS
GENZYME CORPORATION $16,032.0008/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261155226348 CMS
GENZYME CORPORATION $1,677.0008/09/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155226350 CMS
GENZYME CORPORATION $23.2008/09/2024 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261155226352 CMS
Genentech USA, Inc. $330.0007/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075648 CMS
Regeneron Pharmaceuticals, Inc. $1,292.0006/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401245 CMS
Regeneron Pharmaceuticals, Inc. $2,584.0006/07/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401247 CMS
Genentech USA, Inc. $2,640.0005/19/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075639 CMS
Genentech USA, Inc. $138.8305/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133075644 CMS
GlaxoSmithKline, LLC. $10,725.0005/15/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116619711 CMS
GlaxoSmithKline, LLC. $3,575.0005/01/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116341612 CMS
GlaxoSmithKline, LLC. $5.5104/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116204027 CMS
GlaxoSmithKline, LLC. $169.0704/26/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116696417 CMS
AstraZeneca Pharmaceuticals LP $2,148.0004/18/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105543227 CMS
GlaxoSmithKline, LLC. $75.4104/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261115823021 CMS
GlaxoSmithKline, LLC. $65.2104/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116223761 CMS
Chiesi USA, Inc. $65.4403/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811398 CMS
Chiesi USA, Inc. $28.5703/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811402 CMS
Chiesi USA, Inc. $270.0703/30/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811407 CMS
Chiesi USA, Inc. $28.5703/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811411 CMS
Chiesi USA, Inc. $4,565.0003/05/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261151811394 CMS
GENZYME CORPORATION $30.7402/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139598407 CMS
AstraZeneca Pharmaceuticals LP $135.0002/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105527047 CMS
GlaxoSmithKline, LLC. $650.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261116444185 CMS
Regeneron Pharmaceuticals, Inc. $1,358.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401241 CMS
Regeneron Pharmaceuticals, Inc. $2,716.0001/26/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261114401243 CMS
GENZYME CORPORATION $9,602.5001/16/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139598495 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $29,659.98 20
PY2020 $10,065.80 7
PY2021 $35,700.61 14
PY2022 $9,030.73 4
PY2023 $8,689.32 13
PY2024 $77,602.25 43
PY2025 $75,793.82 37

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MONICA KRAFT, NPI 1023192937. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1023192937.
APA 7
IndustryPayments. (2026). MONICA KRAFT, NPI 1023192937 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1023192937
Bluebook
MONICA KRAFT, NPI 1023192937, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1023192937.

Source: Centers for Medicare & Medicaid Services, Open Payments.